跳至主要内容
临床试验/NCT03779555
NCT03779555终止不适用

Lenalidomide Adherence in Older Adults: A Pilot Prospective Cohort Study of Oral Therapy for Multiple Myeloma

Washington University School of Medicine1 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2019年12月13日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
17
试验地点
1
主要终点
Adherence rate as measured by the number of days in which the lenalidomide pill bottle was open

研究概览

简要总结

To describe patterns of adherence and pilot baseline measures to investigate factors associated with lower adherence to lenalidomide in older adults with myeloma.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Receiving lenalidomide for treatment of multiple myeloma.
  • Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites
  • Able to read and understand English.
  • Able to understand and willing to sign an IRB-approved written informed consent document.

排除标准

  • Estimated life expectancy <6 months.
  • Anticipated duration of lenalidomide therapy <3 months.
  • Residing in a nursing facility where their medications are administered to them OR patient reports they do not self-administer their own medications.

结局指标

主要结局

Adherence rate as measured by the number of days in which the lenalidomide pill bottle was open

时间窗: Through completion of study (estimated to be 3 months)

-Participants will be given a pill diary in which they will record if they opened the pill bottle without taking a medication (e.g. to ascertain remaining supply) to adjust the adherence rate accordingly

次要结局

  • Adherence rate as measured by a modified Brief Adherence Rating Scale(Through completion of study (estimated to be 3 months))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验